Express News | NYSE Order Imbalance 55867.0 Shares on Buy Side
Reuters15:50 ET
CONMED Corporation (NYSE:CNMD) Q1 2024 Earnings Call Transcript
Yahoo FinanceApr 26 08:36 ET
CONMED First Quarter 2024 Earnings: Beats Expectations
Yahoo FinanceApr 26 06:45 ET
Conmed Is Maintained at Overweight by JP Morgan
Conmed Is Maintained at Overweight by JP Morgan
Dow JonesApr 25 13:49 ET
CONMED (CNMD) Q1 Earnings & Revenues Surpass Estimates
Yahoo FinanceApr 25 12:44 ET
Express News | CONMED Shares Are Trading Lower After the Company Reported Q1 Financial Results. Needham, Piper Sandler and Wells Fargo Lowered Their Respective Price Targets on the Stock
BenzingaApr 25 11:48 ET
Conmed Appoints New Chief Operating Officer
MassDeviceApr 25 10:16 ET
Conmed Price Target Cut to $95.00/Share From $100.00 by Piper Sandler
Conmed Price Target Cut to $95.00/Share From $100.00 by Piper Sandler
Dow JonesApr 25 09:02 ET
Express News | Piper Sandler Maintains Overweight on Conmed, Lowers Price Target to $95
BenzingaApr 25 08:51 ET
Analyst Scoreboard: 5 Ratings For Conmed
Ratings for Conmed (NYSE:CNMD) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.In the table below, you'll find a summary of their recent rati
BenzingaApr 25 08:01 ET
Express News | Conmed Corporation : Wells Fargo Cuts Target Price to $77 From $98
ReutersApr 25 07:22 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: SI-Bone (SIBN), Conmed (CNMD) and Chemed (CHE)
TipRanksApr 25 07:20 ET
Express News | Conmed Corp : BofA Global Research Cuts Price Objective to $85 From $100
ReutersApr 25 06:58 ET
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating
Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating.
MT NewswiresApr 25 06:20 ET
Conmed's Resilient Performance and Promising Outlook Merit a Buy Rating
TipRanksApr 25 06:05 ET
Conmed Is Maintained at Buy by Needham
Conmed Is Maintained at Buy by Needham
Dow JonesApr 25 06:04 ET
Conmed Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/25/2024 60.9% Needham $129 → $107 Maintains Buy 02/01/2024 50.38% Piper Sandler $130 → $100 Maintains O
BenzingaApr 25 05:53 ET
Express News | Conmed Corp : Needham Cuts Target Price to $107 From $129
ReutersApr 25 05:51 ET
Express News | Conmed Corp : JP Morgan Cuts Target Price to $75 From $115
Moomoo 24/7Apr 24 23:44 ET
Conmed (CNMD) Reports Q1 Earnings: What Key Metrics Have to Say
Yahoo FinanceApr 24 19:00 ET
No Data
No Data